To the best of our knowledge, the current literature on the role of CASP4 in glioma immunotherapy and chemotherapy is superficial and limited in scope; therefore, we chose to conduct an in-depth and comprehensive analysis of the role of CASP4 in the treatment of glioma. The gene discussed is CASP4; the disease is glioma.